These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16963622)

  • 81. [Potentiation by certain sulfonamides of hypoglycemic effects of insulin administered by digestive route; study in normal or depancreatized dogs].
    LOUBATIERES A; BOUYARD P; SASSINE A; FRUTEAU DE LACLOS C
    C R Seances Soc Biol Fil; 1956; 150(12):2241-4. PubMed ID: 13437578
    [No Abstract]   [Full Text] [Related]  

  • 82. Experimental studies on the mode of action of biguanides.
    DAWEKE H; BACH I
    Metabolism; 1963 Apr; 12():319-32. PubMed ID: 14025569
    [No Abstract]   [Full Text] [Related]  

  • 83. Successive measured injections of tracer as a method for determining characteristics of accumulation and turnover in higher animals with access limited to blood: tests in hydrodynamic systems and initial observations on insulin action in dogs.
    WRENSHALL GA; HETENYI G
    Metabolism; 1959 Jul; 8(4 Pt 2):531-43. PubMed ID: 13666399
    [No Abstract]   [Full Text] [Related]  

  • 84. Insulin like conditioned hypoglycemic response in dogs.
    SEGURA ET
    Acta Physiol Lat Am; 1962; 12():342-5. PubMed ID: 13987713
    [No Abstract]   [Full Text] [Related]  

  • 85. [Effect of prolonged intra-arterial administration of small quantities of insulin on peripheral glucose consumption].
    BELLENS R
    C R Seances Soc Biol Fil; 1958; 152(7):1210-2. PubMed ID: 13619222
    [No Abstract]   [Full Text] [Related]  

  • 86. [Hypoglycemic action of insulin-zinc-globin product].
    SPASOWICZ T
    Pol Tyg Lek (Wars); 1954 Jan; 9(4):121-2. PubMed ID: 13166700
    [No Abstract]   [Full Text] [Related]  

  • 87. [Hypoglycemic action of N-3, 4-dimethylbenzoyl-sulfanilamide in normal dogs].
    GARCIA-BLANCO J; ANTON V
    Rev Esp Fisiol; 1958 Jun; 14(2):119-21. PubMed ID: 13579535
    [No Abstract]   [Full Text] [Related]  

  • 88. [Insulin with prolonged action].
    Policlinico Prat; 1958 Mar; 65(9):345-6. PubMed ID: 13553833
    [No Abstract]   [Full Text] [Related]  

  • 89. [Insulin; mechanism of action and clinical use].
    KOGAN-IASNYI VM; SHUL'GA IuD
    Klin Med (Mosk); 1958 Oct; 36(10):79-86. PubMed ID: 13612007
    [No Abstract]   [Full Text] [Related]  

  • 90. [Do the hypoglycemic sulfamides potentiate the hypoglycemic effects of endogenous insulin].
    LOUBATIERES A; BOUYARD P; SASSINE A; DE LACLOS CF
    C R Seances Soc Biol Fil; 1957; 151(5):826-8. PubMed ID: 13500669
    [No Abstract]   [Full Text] [Related]  

  • 91. [Interpretation of data obtained from blood insulin levels].
    VILACLARA MIR J
    Rev Iber Endocrinol; 1963; 10():53-5. PubMed ID: 13997208
    [No Abstract]   [Full Text] [Related]  

  • 92. [Synergistic action of sulfonamides & insulin in recently pancreatectomized dogs].
    URGOITI EJ
    Rev Soc Argent Biol; 1957; 33(6-8):305-8. PubMed ID: 13579650
    [No Abstract]   [Full Text] [Related]  

  • 93. MetAP2 inhibitor treatment of high-fat and -fructose-fed dogs: impact on the response to oral glucose ingestion and a hyperinsulinemic hyperglycemic clamp.
    Moore MC; Coate KC; Scott M; Kraft G; Vath JE; Hughes TE; Farmer B; Cherrington AD
    Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E514-E524. PubMed ID: 31990576
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10.
    Kuehl PJ; Cherrington A; Dobry DE; Edgerton D; Friesen DT; Hobbs C; Leach CL; Murri B; Neal D; Lyon DK; Vodak DT; Reed MD
    AAPS PharmSciTech; 2014 Dec; 15(6):1545-50. PubMed ID: 25106135
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design.
    Strack T; Martinez L; Del Prato S; Blonde L; Göke B; Woo V; Millward A; Gomis R; Canovatchel B; Lawrence D; Freemantle N
    Diabetes Metab Syndr Obes; 2009 Jan; 2():1-10. PubMed ID: 21437114
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine.
    Edgerton DS; Cherrington AD; Neal DW; Scott M; Lautz M; Brown N; Petro J; Hobbs CH; Leach C; Del Parigi A; Strack TR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):970-5. PubMed ID: 19098161
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inhalation of human insulin is associated with improved insulin action compared with subcutaneous injection and endogenous secretion in dogs.
    Edgerton DS; Stettler KM; Neal DW; Scott M; Bowen L; Wilson W; Hobbs CH; Leach C; Strack TR; Cherrington AD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1258-64. PubMed ID: 16963622
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inhalation of human insulin (exubera) augments the efficiency of muscle glucose uptake in vivo.
    Edgerton DS; Cherrington AD; Williams P; Neal DW; Scott M; Bowen L; Wilson W; Hobbs CH; Leach C; Kuo MC; Strack TR
    Diabetes; 2006 Dec; 55(12):3604-10. PubMed ID: 17130510
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.